A5044232183- Tuberculosis Research and Epidemiology
- Cancer Research and Treatments
- Mycobacterium research and diagnosis
- Bacteriophages and microbial interactions
- Diagnosis and treatment of tuberculosis
- Pregnancy and Medication Impact
- Gut microbiota and health
- Inflammatory Bowel Disease
- SARS-CoV-2 and COVID-19 Research
- Nanoplatforms for cancer theranostics
- Cancer Cells and Metastasis
- Probiotics and Fermented Foods
- COVID-19 Clinical Research Studies
- Monoclonal and Polyclonal Antibodies Research
- vaccines and immunoinformatics approaches
- Selenium in Biological Systems
- Nanoparticles: synthesis and applications
- Moringa oleifera research and applications
- Digestive system and related health
- Immunodeficiency and Autoimmune Disorders
- Hepatitis C virus research
- Advanced Nanomaterials in Catalysis
- Immune responses and vaccinations
- Pneumocystis jirovecii pneumonia detection and treatment
- Cancer-related molecular mechanisms research
Mashhad University of Medical Sciences
2015-2024
Shariati Hospital
2024
GTx (United States)
2021
Université de Bordeaux
2021
Institut de Neurosciences Cognitives et Intégratives d’Aquitaine
2021
Centre National de la Recherche Scientifique
2021
Mayo Clinic
2021
WinnMed
2021
Precision Therapeutics (United States)
2021
Tehran University of Medical Sciences
2021
Inflammatory bowel disease (IBD) is defined by the chronic inflammation of digestive tract. Ulcerative colitis one most prevalent IBDs. The increase in mucosal expression angiotensin II (AT-II) suggests a possible role AT-II colitis-associated inflammation. Here, we examined potential therapeutic effects combination therapy regarding valsartan (Val), as an receptor blocker, with sulfasalazine (SSZ) murine model. DSS induced was initiated administration dextran sodium sulfate (DSS) male...